26 de março de 2021

Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma.


 

Nenhum comentário:

Postar um comentário